We present a patient with an acute kidney injury thought secondary to acute interstitial nephritis as a result of vedolizumab maintenance therapy for Crohn's disease. This appears to be a rare but serious side effect in patients receiving this treatment which clinicians should consider in the event of renal dysfunction.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606757 | PMC |
http://dx.doi.org/10.1136/bcr-2021-243568 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!